ADURO BIOTECH, INC. Human Resources Contracts & Agreements
41 Contracts & Agreements
- Bonus & Incentive Agreements (12 contracts)
- Compensation Agreements (4)
- Consulting Agreements (3)
- Employment Agreements (10)
- Separation Agreements (5)
- Severance Agreements (7)
- Amended and Restated 2015 Equity Incentive Plan (Filed With SEC on August 7, 2023)
- Separation Agreement between the Registrant and Alan Glicklich, dated January 26, 2022 (Filed With SEC on March 17, 2022)
- Form of Employment Agreement (Canada) (Filed With SEC on October 7, 2020)
- Form of Employment Agreement (US) (Filed With SEC on October 7, 2020)
- Form of Consulting Agreement (Filed With SEC on October 7, 2020)
- Form of Separation Agreement (Stephen T. Isaacs) (Filed With SEC on October 7, 2020)
- Form of Separation Agreement (Standard) (Filed With SEC on October 7, 2020)
- Amendment to the Aduro Biotech, Inc. Amended and Restated Severance Plan and Summary Plan Description (Filed With SEC on July 2, 2020)
- Amended and Restated Executive Employment Agreement by and between the Company and Stephen T. Isaacs, dated July 2, 2020 (Filed With SEC on July 2, 2020)
- Consulting Agreement, dated as of June 1, 2020, by and between Aduro Biotech, Inc. and Andrea van Elsas, Ph.D (Filed With SEC on June 2, 2020)
- Retention Bonus Agreement dated January 10, 2020, between the Company and Stephen T. Isaacs (Filed With SEC on March 9, 2020)
- Amendment No. 2 to Executive Employment Agreement dated January 13, 2020, between the Company and Stephen T. Isaacs (Filed With SEC on March 9, 2020)
- Retention Bonus Agreement dated January 9, 2020, between the Company and Dimitry Nuyten (Filed With SEC on March 9, 2020)
- Retention Bonus Agreement dated January 9, 2020, between the Company and Celeste Ferber (Filed With SEC on March 9, 2020)
- Retention Bonus Agreement dated January 9, 2020, between the Company and Blaine Templeman (Filed With SEC on March 9, 2020)
- Consulting Agreement dated January 22, 2020, between the Company and Danforth Advisors, LLC (Filed With SEC on January 23, 2020)
- Offer of Employment Letter of Chief Medical Officer (Filed With SEC on August 1, 2019)
- Offer of Employment Letter of Interim Chief Financial Officer (Filed With SEC on August 1, 2019)
- Aduro Biotech, Inc. Non-Employee Director Compensation Policy (Filed With SEC on May 7, 2019)
- Non-Employee Director Compensation Policy (Filed With SEC on August 1, 2018)
- Confidential Separation Agreement and General Release between Aduro Biotech, Inc. and Gregory Schafer dated March 1, 2018 (Filed With SEC on March 1, 2018)
- Confidential Separation Agreement and General Release between Aduro Biotech, Inc. and Dirk Brockstedt dated January 1, 2018 (Filed With SEC on March 1, 2018)
- Addendum to Employment Agreement between Aduro Biotech Holdings, Europe B.V. and Mr. Andrea Van Elsas dated October 4, 2017 (Filed With SEC on March 1, 2018)
- Employment Agreement between Aduro Biotech Holdings, Europe B.V. and Mr. Andrea Van Elsas dated October 30, 2015 (Filed With SEC on March 1, 2018)
- Aduro Biotech, Inc. Non-Employee Director Compensation Policy Approved by the Board of Directors on March 30, 2015 As Amended on June 21, 2016 (Filed With SEC on May 2, 2017)
- ADURO BIOTECH, INC. AMENDED AND RESTATED SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION Effective Date: December 9, 2016 (Filed With SEC on March 1, 2017)
- ADURO BIOTECH, INC. AMENDED AND RESTATED SEVERANCE PLAN AND SUMMARY PLANDESCRIPTION Effective Date: December 9, 2016 ADURO BIOTECH, INC. AMENDED AND RESTATED SEVERANCE PLAN AND... (Filed With SEC on December 15, 2016)
- ADURO BIOTECH, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2015 EQUITY INCENTIVE PLAN) (Filed With SEC on September 14, 2016)
- SEVERANCE AGREEMENT (Filed With SEC on April 14, 2015)
- ADURO BIOTECH, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY APPROVED BY THE BOARD OF DIRECTORS MARCH 30, 2015 (Filed With SEC on April 6, 2015)
- ADURO BIOTECH, INC. 2015 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on April 6, 2015)
- ADURO BIOTECH, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 30, 2015 APPROVED BY THE STOCKHOLDERS:APRIL 1, 2015 IPO DATE/EFFECTIVE DATE:[ ], 2015 (Filed With SEC on April 6, 2015)
- ADURO BIOTECH, INC. SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION Plan Effective Date: March 4, 2015 -1- ADURO BIOTECH, INC. SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION (Filed With SEC on March 11, 2015)
- SEVERANCE AGREEMENT (Filed With SEC on March 11, 2015)
- SEVERANCE AGREEMENT (Filed With SEC on March 11, 2015)
- AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 11, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 11, 2015)
- NON-QUALIFIED STOCK OPTION AGREEMENT UNDER THE TRITONBIOSYSTEMS, INC. 2001 EQUITY INCENTIVE PLAN (Filed With SEC on March 11, 2015)
- TRITON BIOSYSTEMS, INC. 2001 EQUITY INCENTIVE PLAN (Filed With SEC on March 11, 2015)
- ONCOLOGIC, INC. 2000 LONG-TERM INCENTIVE PLAN SUMMARY OF STOCK OPTION GRANT (Filed With SEC on March 11, 2015)
